About this document
Ocrelizumab (Ocrevus) (CP - PHAR.335) PDF by inventeunmail is a document available to read on EtoBox.
The clinical policy outlines the medical necessity criteria for the use of Ocrelizumab (Ocrevus) in treating multiple sclerosis, including specific diagnoses and documentation requirements. It specifies initial and continued therapy criteria, dosage guidelines, and contraindications, while also detailing the approval durations for different lines of business. The policy emphasizes that coverage decisions are subject to all terms and conditions of the relevant health plans and regulatory requirements.
- Author
- inventeunmail
- Language
- EN